Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 39119
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesPAMAM dendrimer G2.0 succinamic acid (PAMAM G2.0 succinamic acid) is a polyamidoamine (PAMAM) dendrimer with succinamic acid termini.1 It has 16 surface groups. PAMAM G2.0 succinamic acid is an antagonist for the pore-forming channels anthrax toxin protective antigen 63 (PA63; IC50 = 879 nM) in lipid bilayers.2 It is active against S. aureus.3 PAMAM G2.0 succinamic acid inhibits plaque formation induced by Middle East respiratory syndrome coronavirus (MERS-CoV) in Vero cells when used at a concentration of 10 µM.1
WARNING This product is not for human or veterinary use.
1. A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus. J. Med. Virol. 92(9), 1665-1670 (2020).
2. Impact of dendrimer terminal group chemistry on blockage of the anthrax toxin channel: A single molecule study. Toxins (Basel) 8(11), 337 (2016).
3. Structure-